They also increase non-HDL-C and LDL clearance by promoting the expression of low-density lipoprotein receptors concentrated in hepatocytes,23,24 which is an important means to reduce ASCVD events,25, 26, 27 and effectively reduce the risk of recurrent cerebral infarction.28 The gene discussed is VLDLR; the disease is cerebral infarction.